Portugal – Plasma extracts – Plasma Fresco Congelado resultante de processo de fracionamento
Opportunity Score
Confidence: 60%
Complexity: medium
9 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Public tender for the acquisition of plasma-derived medications from fractionation of exclusively Portuguese human plasma, sourced from IPST IP, CHUP EPE, and CHUSJ EPE. The contract covers supplies with an estimated value of €2,000,000 and a duration of 7 months. The procedure is open, with electronic submission required in Portuguese. Award criteria include quality (60%) and price (40%). The tender notice shows inconsistencies in lot structure and lacks detailed procurement documents.
Strengths
Documents available
Open procedure
Medium complexity
Risks
Submission deadline in 9 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Open procedure with electronic submission required.
- Submission in Portuguese only.
- Tender must comply with requirements in procurement documents and ESPD.
Award Criteria
Qualidade
Qualidade
| Criterion | Type |
|---|---|
Qualidade Qualidade | Quality |
Buyer
Name
Instituto Português do Sangue e da Transplantação, IP
Location
Lisboa, PRT
Website
Identifier
502423943
Lots (1)
Acquisition of plasma-derived medications from fractionation of exclusively Portuguese human plasma.
Procurement Details
Publication
26 May 2026
Deadline
24 Jun 2026, 23:59
Procedure
open
Contract
supplies
Duration
7 MONTH
Language
POR
Publication #
358247-2026
Classification
Performance: Portugal
Documents (2)
Opportunity Score
Confidence: 60%
Complexity: medium
9 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation